|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, Lymphoid Disorder, 6q Deletion
Test Code16593
CPT Codes
88271, 88275
Preferred Specimen
3 mL bone marrow or 5 mL whole blood collected in a sodium heparin (green-top) tube
Minimum Volume
1 mL bone marrow • 3 mL whole blood
Other Acceptable Specimens
Bone marrow or whole blood collected in: sodium heparin (royal blue-top) tube, sodium heparin lead-free (tan-top) tube • 5x5 mm lymph node submitted in culture transport medium • Bone marrow in culture transport medium
Instructions
Clinical history and reason for referral are required with test order. Prior therapy and transplant history should be provided with test order.
Specimen viability decreases during transit. Send specimen to testing laboratory for viability determination. Do not freeze. Do not reject.
Note: 100-300 interphase cells are microscopically analyzed for probe signal patterns, indicating the copy number for the MYB region of chromosome 6q23.
If results are not possible, the test order may be canceled and replaced with a Cytogenetics Communication.
Specimen viability decreases during transit. Send specimen to testing laboratory for viability determination. Do not freeze. Do not reject.
Note: 100-300 interphase cells are microscopically analyzed for probe signal patterns, indicating the copy number for the MYB region of chromosome 6q23.
If results are not possible, the test order may be canceled and replaced with a Cytogenetics Communication.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: See instructions
Refrigerated: See instructions
Frozen: See instructions
Refrigerated: See instructions
Frozen: See instructions
Methodology
Fluorescence in situ Hybridization (FISH)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Sun-Fri; Report available: 5 days
Reference Range
See Laboratory Report
Clinical Significance
Chromosome 6q deletion is a frequent abnormality in lymphoid malignancies including acute lymphoblastic leukemia, chronic lymphoid disorders, non-Hodgkin lymphoma, and multiple myeloma. It may be the sole clonal abnormality in as much as 30% of cases. Deletions may be small and difficult to resolve using conventional chromosome analysis. Deletion of MYB may be associated with loss of recessive tumor suppressor gene and may be an initial step in leukemogenesis.